We are live on ! Find out more
NHAS

Novo Holdings A/S Portfolio holdings

AUM $1.23B
1-Year Est. Return 81.32%
This Fund
S&P 500
This Quarter Est. Return
-1.94%
1 Year Est. Return
+81.32%
3 Year Est. Return
+192.63%
5 Year Est. Return
+125.03%
10 Year Est. Return
+943.65%
AUM
$1.03B
AUM Growth
+$14.4M
Cap. Flow
+$58.5M
Cap. Flow %
5.7%
Top 10 Hldgs %
96.97%
Holding
14
New
4
Increased
–
Reduced
–
Closed
1

Top Buys

Rank Stock Value
1
OTIC
Otonomy, Inc.
OTIC
+$43M
2
ELDN icon
Eledon Pharmaceuticals
ELDN
+$18.9M
3
ZSPH
ZS PHARMA INC COMS TK (DE)
ZSPH
+$16.7M
4
XENT
Intersect ENT, Inc
XENT
+$5.27M

Top Sells

Rank Stock Value
1
WMGI
Wright Medical Group Inc
WMGI
+$18.4M

Sector Composition

Rank Sector Weight
1 Healthcare 54.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VTI icon
1
Vanguard Total Stock Market ETF
VTI
$659B
$302M 29.41%
2,979,100
– –
ISEE
2
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$268M 26.18%
6,896,819
– –
VGK icon
3
Vanguard FTSE Europe ETF
VGK
$30.2B
$116M 11.31%
2,101,000
– –
INGN icon
4
Inogen
INGN
$172M
$112M 10.89%
5,419,449
– –
OTIC
5
DELISTED
Otonomy, Inc.
OTIC
$52.2M 5.09%
+2,175,025
New +$43M
ALDR
6
DELISTED
Alder Biopharmaceuticals
ALDR
$40.6M 3.96%
3,201,183
– –
AKBA icon
7
Akebia Therapeutics
AKBA
$341M
$33.6M 3.27%
1,516,387
– –
FLXN
8
DELISTED
Flexion Therapeutics, Inc.
FLXN
$32.6M 3.17%
1,783,131
– –
ZSPH
9
DELISTED
ZS PHARMA INC COMS TK (DE)
ZSPH
$19.9M 1.94%
+506,730
New +$16.7M
TTPH
10
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$18M 1.75%
45,000
– –
ELDN icon
11
Eledon Pharmaceuticals
ELDN
$288M
$15.5M 1.51%
+6,636
New +$18.9M
XENT
12
DELISTED
Intersect ENT, Inc
XENT
$5.42M 0.53%
+350,000
New +$5.27M
WMGI
13
DELISTED
Wright Medical Group Inc
WMGI
– –
-585,759
Closed -$18.4M

Similar funds

HCA
Harbor Capital Advisors Chicago, Illinois $1.23B AUM 30.56% 1-Year Est. Return
GX
Greylock XIV Menlo Park, California $1.24B AUM
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
FLII
First Long Island Investors Jericho, New York $1.23B AUM 14.42% 1-Year Est. Return
CA
Cullinan Associates Louisville, Kentucky $1.24B AUM 28.12% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
WTA
Washington Trust Advisors Wellesley, Massachusetts $1.24B AUM 22.58% 1-Year Est. Return
CCA
Clearwater Capital Advisors Hoffman Estates, Illinois $1.24B AUM 15.23% 1-Year Est. Return

Novo Holdings A/S's Q3 2014 Portfolio in Review

As of Q3 2014, Novo Holdings A/S held 14 positions worth $1.03B, up 1.4% from $1.01B the previous quarter. Its ten largest holdings account for 97% of the portfolio.

Novo Holdings A/S deployed $58.5M of net new capital in Q3 2014, opening 4 new positions. Its largest new stake was Otonomy, Inc.: 2,175,025 shares worth $52.2M.

By sector, the portfolio is most concentrated in Healthcare at 54% of assets, down from 56% a quarter earlier.

On the sell side, the most notable exit was Wright Medical Group Inc, an estimated $18.4M sold.

  • Novo Holdings A/S's largest Q3 2014 buy was Otonomy, Inc.: 2,175,025 shares worth $52.2M.
  • Novo Holdings A/S fully exited Wright Medical Group Inc in Q3 2014, selling an estimated $18.4M.
  • Novo Holdings A/S's ten largest holdings make up 97% of its $1.03B portfolio in Q3 2014.
  • Novo Holdings A/S opened 4 new positions and closed 1 in Q3 2014.
  • Novo Holdings A/S's portfolio value rose 1.4% quarter-over-quarter to $1.03B.

Based on Novo Holdings A/S's 13F filing for Q3 2014, filed 14 Nov 2014.